Single Use Bioprocessing (SUB) Market Size, Share, Growth, and Industry Analysis, By Type ( Filtration Assemblies,Media Bags and Containers,Disposable/Single-use Bioreactors,Disposable Mixers,Other ), By Application ( Filtration,Cell Culture,Purification,Other ), Regional Insights and Forecast to 2035

Single Use Bioprocessing (SUB) Market Overview

Global Single Use Bioprocessing (SUB) Market size is forecasted to be worth USD 686.76 million in 2026, expected to achieve USD 1068.59 million by 2035 with a CAGR of 5.0%.

The single use bioprocessing (SUB) market is expanding rapidly due to increasing demand for flexible, contamination-free, and cost-efficient biopharmaceutical production systems. Disposable bioreactors account for approximately 36% of total adoption due to scalability and reduced cleaning requirements. Filtration assemblies contribute nearly 28% of usage, supporting purification and separation processes. Media bags and containers represent around 22% of demand, ensuring safe storage and transfer of biological materials. Cell culture applications account for approximately 41% of total usage in bioprocessing workflows. Pharmaceutical and biotechnology companies contribute nearly 62% of total demand. Reduced risk of cross-contamination and faster turnaround times continue to drive the single use bioprocessing (SUB) market globally.

The United States single use bioprocessing (SUB) market accounts for approximately 39% of global demand, driven by strong biopharmaceutical manufacturing infrastructure. Around 68% of biopharma companies in the U.S. utilize single-use systems to improve efficiency. Disposable bioreactors contribute nearly 37% of usage in the country. Filtration systems account for approximately 29% of applications due to high demand for purification processes. Contract manufacturing organizations represent around 33% of system usage. Increasing biologics production and technological advancements are supporting market expansion in the United States.

Download FREE Sample to learn more about this report.

Key Findings

• Key Market Driver: 62% biopharma demand, 41% cell culture usage, and 36% disposable bioreactor adoption drive single use bioprocessing market growth globally.
• Major Market Restraint: 43% waste disposal concerns, 38% material limitations, and 34% regulatory challenges restrict single use bioprocessing market expansion.
• Emerging Trends: 45% automation adoption, 39% modular facility growth, and 36% continuous processing usage shape single use bioprocessing market trends.
• Regional Leadership: 39% North America share, 30% Europe contribution, and 23% Asia-Pacific demand dominate single use bioprocessing market distribution.
• Competitive Landscape: Top 10 companies hold 57% share, with 44% focusing on innovation and 38% on expansion strategies.
• Market Segmentation: 36% bioreactors, 28% filtration assemblies, and 41% cell culture applications dominate segmentation.
• Recent Development: 42% innovation, 37% automation integration, and 35% facility expansion indicate market advancement.

Single Use Bioprocessing (SUB) Market Latest Trends

The single use bioprocessing (SUB) market is evolving with rapid adoption of disposable technologies across biopharmaceutical manufacturing. Disposable bioreactors dominate with approximately 36% share due to flexibility and reduced contamination risk. Filtration systems account for nearly 28% of applications, supporting purification processes. Media bags and containers contribute around 22% of usage for safe handling of biological materials. Cell culture applications represent approximately 41% of total demand driven by biologics production. Automation integration has reached nearly 45%, improving process control and operational efficiency. Modular facilities account for approximately 39% of installations, enabling faster setup and scalability. Continuous bioprocessing adoption stands at around 36%, enhancing productivity. Contract manufacturing organizations contribute nearly 33% of system usage. Technological advancements are improving reliability and performance. These trends indicate strong expansion of the single use bioprocessing (SUB) market.

Single Use Bioprocessing (SUB) Market Dynamics

DRIVER

"Increasing demand for biologics and flexible manufacturing systems."

The single use bioprocessing (SUB) market is driven by rising demand for biologics and need for efficient, flexible production systems across pharmaceutical and biotechnology industries. Approximately 62% of demand is generated by biopharma companies focusing on biologics manufacturing. Cell culture applications account for nearly 41% of total usage, highlighting their importance in production workflows. Disposable bioreactors contribute around 36% of adoption due to scalability and reduced contamination risk. Contract manufacturing organizations represent approximately 33% of system usage, supporting outsourcing trends. Manufacturers are focusing on improving system efficiency and reliability. Increasing production of vaccines and biologics is further driving demand. These factors collectively support steady growth in the single use bioprocessing market.

RESTRAINT

"Waste disposal concerns and material limitations."

The single use bioprocessing (SUB) market faces restraints due to challenges related to disposal of single-use plastics and material compatibility issues. Approximately 43% of users report concerns about waste management and environmental impact. Material limitations affect nearly 38% of applications, restricting use in certain processes. Regulatory compliance challenges impact around 34% of system adoption. The reliance on plastic components raises sustainability concerns across industries. Manufacturers are focusing on developing recyclable and biodegradable materials. High disposal costs also affect operational efficiency. These factors collectively limit growth in the single use bioprocessing market.

OPPORTUNITY

"Expansion of modular facilities and automation integration."

The single use bioprocessing (SUB) market presents strong opportunities through increasing adoption of modular facilities and automation technologies. Automation integration has reached approximately 45% of installations, improving process control and efficiency. Modular facilities account for nearly 39% of new developments, enabling faster production setup. Continuous bioprocessing adoption stands at around 36%, enhancing productivity and scalability. Emerging markets are contributing significantly to new adoption due to expanding biopharma sectors. Manufacturers are focusing on innovative system designs to improve performance. Increasing demand for flexible production systems is supporting market expansion. These factors highlight strong growth opportunities.

CHALLENGE

"Regulatory complexity and scalability limitations."

The single use bioprocessing (SUB) market faces challenges related to regulatory compliance and scalability in large-scale production. Approximately 34% of users report regulatory challenges affecting adoption and implementation. Scalability limitations impact nearly 31% of production facilities when transitioning from small-scale to large-scale operations. Ensuring consistent product quality remains a key concern in bioprocessing. Manufacturers are focusing on improving system reliability and validation processes. Technical complexity also affects system integration in existing facilities. These challenges highlight the need for continuous innovation and regulatory alignment in the single use bioprocessing market.

Single Use Bioprocessing (SUB) Market Segmentation

Download FREE Sample to learn more about this report.

By Type

Filtration Assemblies: Filtration assemblies account for approximately 28% of the single use bioprocessing market, driven by their critical role in separation and purification processes across biologics manufacturing. These systems are widely used in upstream and downstream operations, ensuring removal of impurities and maintaining product quality. Around 41% of bioprocess workflows incorporate filtration at multiple stages, highlighting their operational importance. The demand for high-efficiency filtration systems is increasing due to strict quality standards in pharmaceutical production. Manufacturers are focusing on improving membrane performance and reducing processing time. Disposable filtration systems reduce contamination risks and eliminate cleaning requirements. Adoption is increasing across contract manufacturing organizations and research laboratories. Technological advancements are enhancing system reliability and throughput. These factors continue to support steady growth of filtration assemblies in the market.

Media Bags and Containers: Media bags and containers represent approximately 22% of the single use bioprocessing market, supporting safe storage, mixing, and transfer of biological fluids. These components are essential for maintaining sterility during production processes. Around 33% of biopharma facilities rely on disposable containers for fluid handling operations. The demand for flexible and scalable storage solutions is increasing across manufacturing facilities. Manufacturers are focusing on developing durable and leak-proof designs to ensure safety. Single-use bags reduce the need for cleaning and sterilization, improving operational efficiency. These systems are widely used in both upstream and downstream processes. Technological improvements are enhancing material strength and compatibility. The segment continues to expand with increasing biologics production.

Disposable Bioreactors: Disposable bioreactors dominate the single use bioprocessing market with approximately 36% share due to their scalability and operational efficiency in biologics production. These systems are widely used for cell culture applications in pharmaceutical manufacturing. Around 62% of biopharma companies utilize disposable bioreactors for flexible production. They reduce contamination risk and eliminate the need for cleaning processes. Manufacturers are focusing on improving system capacity and control features. The demand for scalable production systems is increasing globally. Disposable bioreactors support faster setup and reduced downtime. Technological advancements are enhancing monitoring and automation capabilities. The segment continues to lead due to strong demand for biologics and vaccines.

Disposable Mixers: Disposable mixers account for approximately 14% of the single use bioprocessing market, supporting mixing operations in biomanufacturing processes. These systems are used for blending media and preparing solutions required for production. Around 39% of production workflows involve mixing processes, highlighting their importance. Manufacturers are focusing on improving mixing efficiency and uniformity. Disposable mixers reduce contamination risk and improve process flexibility. The demand for efficient mixing systems is increasing across pharmaceutical facilities. These systems are widely used in both small-scale and large-scale operations. Technological advancements are improving performance and ease of use. The segment continues to grow steadily with increasing adoption of single-use technologies.

Other: Other components account for approximately 10% of the single use bioprocessing market, including specialized equipment such as sensors and connectors. These systems support various auxiliary functions in bioprocessing workflows. Around 31% of facilities utilize specialized components for customized applications. Manufacturers are focusing on developing innovative solutions to meet specific process requirements. The demand for integrated and multifunctional systems is increasing. These components enhance overall system performance and efficiency. Technological advancements are improving compatibility and reliability. The segment continues to expand gradually with evolving industry needs.

By Application

Filtration: Filtration applications account for approximately 29% of the single use bioprocessing market, driven by the need for purification and separation in biologics production. Filtration systems are used in both upstream and downstream processes to ensure product quality. Around 41% of production workflows rely on filtration at multiple stages. Manufacturers are focusing on improving filtration efficiency and throughput. The demand for high-performance filtration systems is increasing. Disposable filtration systems reduce contamination risks and operational complexity. These systems are widely adopted across pharmaceutical facilities. Technological advancements are enhancing performance and reliability. The segment continues to grow steadily with increasing biologics production.

Cell Culture: Cell culture dominates the single use bioprocessing market with approximately 41% share due to its central role in biologics and vaccine production. These applications involve growing cells for production of therapeutic products. Around 62% of biopharma companies rely on cell culture systems for manufacturing. Disposable bioreactors are widely used in this segment. Manufacturers are focusing on improving cell growth conditions and process efficiency. The demand for biologics is driving growth in this segment. Technological advancements are improving system scalability and monitoring. The segment continues to lead due to increasing pharmaceutical production.

Purification: Purification applications account for approximately 21% of the single use bioprocessing market, supporting downstream processing of biologics. These systems ensure removal of impurities and enhance product quality. Around 36% of production processes involve purification stages. Manufacturers are focusing on improving system efficiency and reliability. The demand for high-quality biologics is increasing. Disposable purification systems reduce contamination risks and operational costs. These systems are widely used in pharmaceutical manufacturing. Technological advancements are enhancing process control. The segment continues to grow steadily with increasing demand for biologics.

Other: Other applications account for approximately 9% of the single use bioprocessing market, including research and development activities. These applications support innovation and testing in biopharmaceutical production. Around 28% of research facilities utilize single-use systems. Manufacturers are focusing on developing flexible and efficient solutions. The demand for advanced research tools is increasing. These applications contribute to overall market growth.

Single Use Bioprocessing (SUB) Market Regional Outlook

Download FREE Sample to learn more about this report.

North America

North America holds approximately 39% share in the single use bioprocessing market, driven by a strong biopharmaceutical industry and advanced manufacturing capabilities. Around 68% of companies utilize SUB systems to improve production efficiency and reduce contamination risks. The region benefits from significant investment in research and development activities. Disposable bioreactors account for nearly 37% of system usage in production facilities. Contract manufacturing organizations contribute approximately 33% of system demand, supporting outsourcing strategies. Manufacturers are focusing on developing advanced and scalable solutions. The demand for biologics and vaccines is increasing steadily. Regulatory support ensures high standards for production quality and safety. Technological advancements are improving automation and monitoring capabilities. The region continues to grow due to strong infrastructure and innovation.

Europe

Europe accounts for approximately 30% of the single use bioprocessing market, supported by strong healthcare infrastructure and regulatory frameworks. Around 52% of facilities focus on improving production efficiency and process safety. The region benefits from well-established pharmaceutical and biotechnology industries. Manufacturers are focusing on developing innovative and sustainable bioprocessing systems. Demand for biologics is increasing across European countries. Research institutions play a key role in technology adoption and development. Automation and modular systems are gaining traction in production facilities. Regulatory compliance supports adoption of advanced technologies. The region continues to grow steadily due to strong healthcare and research capabilities.

Asia-Pacific

Asia-Pacific holds approximately 23% share in the single use bioprocessing market, driven by rapid industrial growth and increasing investment in pharmaceutical manufacturing. Around 58% of demand originates from emerging economies such as China and India. The region is witnessing expansion of contract manufacturing organizations and production facilities. Manufacturers are focusing on cost-effective and scalable solutions. Government initiatives are supporting development of biopharmaceutical infrastructure. Demand for biologics and vaccines is increasing rapidly. Technological adoption is improving across production facilities. The region shows strong growth potential due to rising healthcare demand. Asia-Pacific continues to expand due to increasing investment and industrial development.

Middle East & Africa

The Middle East & Africa region accounts for approximately 8% of the single use bioprocessing market, reflecting emerging adoption trends driven by improving healthcare infrastructure. Around 34% of demand is linked to expanding pharmaceutical and healthcare facilities. The region is witnessing gradual adoption of advanced bioprocessing technologies. Manufacturers are expanding distribution networks to improve market presence. Government investments are supporting healthcare and pharmaceutical development. Demand for efficient and flexible production systems is increasing. Technological adoption is improving across major healthcare centers. The region continues to grow steadily with increasing awareness and investment in biopharmaceutical production.

List of Top Single Use Bioprocessing (SUB) Companies

• Sartorius Stedim Biotech
• Danaher Corporation
• Thermo Fisher Scientific
• Merck KGaA
• Getinge AB
• Eppendorf AG
• Corning
• Entegris
• Avantor
• Cesco Bioengineering Co. Ltd.
• Cellexus
• PBS Biotech Inc.
• Distek Inc.
• ABEC Inc.
• Able Corporation
• Biott Corporation
• G&G Technologies Inc.
• Solida Biotech GmbH
• Satake Chemical Equipment Mfg Ltd.

List of Top Two Companies Market Share

• Sartorius Stedim Biotech holds approximately 19% market share, driven by strong portfolio in single-use bioprocessing systems and global presence.
• Thermo Fisher Scientific accounts for nearly 17% market share, supported by extensive product offerings and advanced biopharma manufacturing solutions.

Investment Analysis and Opportunities

The single use bioprocessing (SUB) market is attracting strong investment due to rising biologics production and demand for flexible manufacturing systems. Approximately 45% of investments are focused on automation technologies to improve process efficiency and reduce operational errors. Modular bioprocessing facilities account for nearly 39% of investment activity, enabling faster setup and scalability of production units. Emerging markets contribute around 34% of new investment opportunities due to expanding pharmaceutical manufacturing infrastructure. Biopharma companies represent approximately 62% of total investment participation, highlighting their dominant role in market growth.

Governments are supporting investments through funding and policy initiatives for biologics production. Manufacturers are expanding production capacity and strengthening global supply chains. Strategic collaborations are enhancing technology development and market penetration. These factors collectively highlight strong investment potential in the single use bioprocessing market.

New Product Development

New product development in the single use bioprocessing market is focused on improving efficiency, scalability, and sustainability of production systems. Approximately 42% of innovations involve advanced automation features to enhance process control and monitoring. Disposable bioreactors account for nearly 36% of new product developments due to high demand for scalable production solutions. Filtration systems contribute around 28% of innovation efforts, supporting purification and separation processes.

Manufacturers are focusing on developing high-performance materials to improve durability and compatibility. Integration of digital monitoring systems is improving real-time process visibility. The demand for flexible and user-friendly systems is increasing across production facilities. Continuous innovation is enhancing product reliability and performance. These developments are shaping the future of the single use bioprocessing market.

Five Recent Developments (2023-2025)

• In 2023, industry focus increased on continuous bioprocessing and cell culture technologies, improving efficiency and scalability in biologics manufacturing workflows.
• In 2023, manufacturers expanded adoption of single-use systems to reduce cross-contamination risks, supporting multi-product production environments in biopharma facilities.
• In 2024, innovation in single-use filtration and consumables increased, with filtration becoming one of the most widely used applications across bioprocessing workflows.
• In 2025, advancements in single-use bags and cold chain solutions improved storage and transport efficiency for biologics and sensitive materials.
• In 2025, companies accelerated facility expansion and modular biomanufacturing adoption, enabling faster production setup and flexible scaling of biologics manufacturing.

Report Coverage of Single Use Bioprocessing (SUB) Market

The report provides comprehensive insights into the single use bioprocessing market, covering key trends, segmentation, and regional performance. Disposable bioreactors account for approximately 36% of total usage, while cell culture applications represent nearly 41% of demand. Regional analysis highlights North America with approximately 39% share, followed by Europe at 30% and Asia-Pacific at 23%.

Automation adoption has reached around 45%, reflecting strong technological advancement. The report includes detailed analysis of market dynamics such as drivers, restraints, opportunities, and challenges. Competitive landscape insights highlight key companies and their strategies. Technological innovations and product developments are also covered. The report provides structured and data-driven insights into market performance and growth factors.